According to Benzinga Pro data, during Q4, Cadiz (NASDAQ:CDZI) posted sales of $142.00 thousand. Earnings were up 24.68%, but Cadiz still reported an overall loss of $5.90 million.
Gainers
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
Toward the end of trading Tuesday, the Dow traded up 0.26% to 36,396.21 while the NASDAQ fell 0.52% to 15,789.51. The S&P also fell, dropping 0.12% to 4,785.52.